Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 25 April, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 519105 | NSE: AVTNPL

AVT Natural Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 24, 2025, 9:58 pm

Market Cap 947 Cr.
Current Price 62.0
High / Low 103/51.0
Stock P/E21.1
Book Value 31.2
Dividend Yield1.29 %
ROCE15.9 %
ROE11.8 %
Face Value 1.00
PEG Ratio-104.02

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for AVT Natural Products Ltd

Competitors of AVT Natural Products Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
GRM Overseas Ltd 1,989 Cr. 330 335/12239.1 60.60.00 %12.9 %18.3 % 2.00
Freshtrop Fruits Ltd 97.8 Cr. 123 175/105 1450.00 %6.40 %51.6 % 10.0
Chamanlal Setia Exports Ltd 1,739 Cr. 336 447/18317.1 1310.67 %20.2 %17.4 % 2.00
Mangalam Global Enterprise Ltd 459 Cr. 13.8 17.0/9.2518.5 6.120.07 %16.6 %14.6 % 1.00
LT Foods Ltd 12,668 Cr. 364 452/18621.3 1050.55 %21.1 %19.3 % 1.00
Industry Average3,910.60 Cr327.3648.46114.440.32%13.13%17.81%3.50

All Competitor Stocks of AVT Natural Products Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 148129149160139134103135154125105122173
Expenses 1081101131261121109211911810997114143
Operating Profit 401936342724111736168830
OPM % 27%15%24%21%19%18%11%12%23%13%8%7%17%
Other Income 2513-1-135-05554
Interest 1111121222123
Depreciation 4333443443333
Profit before tax 361933332018101630158828
Tax % 27%18%25%25%34%21%19%27%26%26%25%17%23%
Net Profit 27162525131481222116622
EPS in Rs 1.741.041.631.640.880.930.550.761.470.720.390.411.42

Last Updated: February 28, 2025, 8:35 pm

Below is a detailed analysis of the quarterly data for AVT Natural Products Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is 173.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Sep 2024) to 173.00 Cr., marking an increase of 51.00 Cr..
  • For Expenses, as of Dec 2024, the value is 143.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Sep 2024) to 143.00 Cr., marking an increase of 29.00 Cr..
  • For Operating Profit, as of Dec 2024, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to 30.00 Cr., marking an increase of 22.00 Cr..
  • For OPM %, as of Dec 2024, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Sep 2024) to 17.00%, marking an increase of 10.00%.
  • For Other Income, as of Dec 2024, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Sep 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
  • For Interest, as of Dec 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
  • For Depreciation, as of Dec 2024, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.00 Cr..
  • For Profit before tax, as of Dec 2024, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Sep 2024) to 28.00 Cr., marking an increase of 20.00 Cr..
  • For Tax %, as of Dec 2024, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 17.00% (Sep 2024) to 23.00%, marking an increase of 6.00%.
  • For Net Profit, as of Dec 2024, the value is 22.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Sep 2024) to 22.00 Cr., marking an increase of 16.00 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 1.42. The value appears strong and on an upward trend. It has increased from 0.41 (Sep 2024) to 1.42, marking an increase of 1.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:09 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 267290261274311328339396485559582517524
Expenses 184216214235269295297339414454461438463
Operating Profit 8374483942334257711061217962
OPM % 31%25%18%14%14%10%12%14%15%19%21%15%12%
Other Income 01215134781021319
Interest 6241235645578
Depreciation 45667711141514131414
Profit before tax 736741333836304561971057158
Tax % 34%37%35%35%36%32%30%24%25%25%26%25%
Net Profit 48422622242421344573775345
EPS in Rs 3.142.761.731.421.611.591.372.232.974.785.083.502.94
Dividend Payout % 20%27%29%28%25%25%29%27%24%21%20%23%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-12.50%-38.10%-15.38%9.09%0.00%-12.50%61.90%32.35%62.22%5.48%-31.17%
Change in YoY Net Profit Growth (%)0.00%-25.60%22.71%24.48%-9.09%-12.50%74.40%-29.55%29.87%-56.74%-36.65%

AVT Natural Products Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:6%
5 Years:9%
3 Years:2%
TTM:0%
Compounded Profit Growth
10 Years:2%
5 Years:21%
3 Years:6%
TTM:-21%
Stock Price CAGR
10 Years:7%
5 Years:14%
3 Years:-21%
1 Year:-29%
Return on Equity
10 Years:14%
5 Years:16%
3 Years:17%
Last Year:12%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:39 am

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 8151515151515151515151515
Reserves 131152171185209223236260295354415454460
Borrowings 355710153681465425374396
Other Liabilities 546444393655565762555686148
Total Liabilities 228237237249275330389378426449524598719
Fixed Assets 45515358575698998982788276
CWIP 30210280002002
Investments 11572838307882858127131
Other Assets 179171175162180215283271329337387390510
Total Assets 228237237249275330389378426449524598719

Below is a detailed analysis of the balance sheet data for AVT Natural Products Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 15.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹460.00 Cr.. The value appears strong and on an upward trend. It has increased from 454.00 Cr. (Mar 2024) to ₹460.00 Cr., marking an increase of 6.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹96.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 43.00 Cr. (Mar 2024) to ₹96.00 Cr., marking an increase of 53.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹148.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 86.00 Cr. (Mar 2024) to ₹148.00 Cr., marking an increase of 62.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹719.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 598.00 Cr. (Mar 2024) to ₹719.00 Cr., marking an increase of 121.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Mar 2024) to ₹76.00 Cr., marking a decrease of 6.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to ₹2.00 Cr., marking an increase of 2.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹131.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2024) to ₹131.00 Cr., marking an increase of 4.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹510.00 Cr.. The value appears strong and on an upward trend. It has increased from 390.00 Cr. (Mar 2024) to ₹510.00 Cr., marking an increase of 120.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹719.00 Cr.. The value appears strong and on an upward trend. It has increased from 598.00 Cr. (Mar 2024) to ₹719.00 Cr., marking an increase of 121.00 Cr..

Notably, the Reserves (460.00 Cr.) exceed the Borrowings (96.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +366812341614-30718745199
Cash from Investing Activity +-14-220-31-10-294-14-4-29-37-78
Cash from Financing Activity +-18-41-12-7-31129-50-6-45-8-15
Net Cash Flow45-1-43-437-3065

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow48.0069.0041.0029.0027.00-3.00-39.0011.0017.0081.0084.0036.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days614758696571886977677678
Inventory Days291248278184205186341235258263342365
Days Payable405937283968824359454497
Cash Conversion Cycle312236300226231188347261275284373346
Working Capital Days162121168155137156232177191175193195
ROCE %51%40%25%17%17%14%11%15%19%27%26%16%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%75.00%
FIIs0.07%0.09%0.10%0.06%0.08%0.07%0.05%0.02%0.15%0.05%0.06%0.06%
DIIs0.01%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%0.02%
Government0.00%0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public24.92%24.89%24.87%24.91%24.89%24.92%24.94%24.96%24.84%24.95%24.92%24.93%
No. of Shareholders29,76733,45235,71537,95238,00039,15746,40448,97550,42351,80756,90354,777

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 1.001.001.001.001.00
Basic EPS (Rs.) 3.505.084.782.972.23
Diluted EPS (Rs.) 3.505.084.782.972.23
Cash EPS (Rs.) 4.415.965.733.973.13
Book Value[Excl.RevalReserv]/Share (Rs.) 30.8328.2624.2120.3718.05
Book Value[Incl.RevalReserv]/Share (Rs.) 30.8328.2624.2120.3718.05
Revenue From Operations / Share (Rs.) 33.9738.2336.7331.8626.03
PBDIT / Share (Rs.) 6.048.097.595.244.21
PBIT / Share (Rs.) 5.127.226.654.243.31
PBT / Share (Rs.) 4.676.866.353.982.94
Net Profit / Share (Rs.) 3.505.084.782.972.23
NP After MI And SOA / Share (Rs.) 3.505.084.782.972.23
PBDIT Margin (%) 17.7621.1720.6616.4316.16
PBIT Margin (%) 15.0818.8718.1013.3012.70
PBT Margin (%) 13.7317.9517.2712.4811.30
Net Profit Margin (%) 10.3013.2913.029.338.57
NP After MI And SOA Margin (%) 10.3013.2913.029.338.57
Return on Networth / Equity (%) 11.3417.9819.7514.5912.37
Return on Capital Employeed (%) 16.0824.6826.5319.6917.03
Return On Assets (%) 8.9014.8316.2310.649.00
Long Term Debt / Equity (X) 0.010.010.010.020.03
Total Debt / Equity (X) 0.070.070.050.150.14
Asset Turnover Ratio (%) 0.921.211.241.181.01
Current Ratio (X) 4.535.755.373.403.32
Quick Ratio (X) 2.572.982.641.721.83
Inventory Turnover Ratio (X) 0.941.451.491.841.30
Dividend Payout Ratio (NP) (%) 25.7119.6716.7221.8524.29
Dividend Payout Ratio (CP) (%) 20.4016.7713.9616.3717.31
Earning Retention Ratio (%) 74.2980.3383.2878.1575.71
Cash Earning Retention Ratio (%) 79.6083.2386.0483.6382.69
Interest Coverage Ratio (X) 13.2023.0225.0419.8911.53
Interest Coverage Ratio (Post Tax) (X) 8.6515.4616.7812.307.12
Enterprise Value (Cr.) 1285.961216.711993.77716.44380.26
EV / Net Operating Revenue (X) 2.492.093.561.480.95
EV / EBITDA (X) 13.999.8717.248.995.93
MarketCap / Net Operating Revenue (X) 2.472.073.551.410.90
Retention Ratios (%) 74.2880.3283.2778.1475.70
Price / BV (X) 2.722.805.392.211.31
Price / Net Operating Revenue (X) 2.472.073.551.410.90
EarningsYield 0.040.060.030.060.09

After reviewing the key financial ratios for AVT Natural Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 5.08 (Mar 23) to 3.50, marking a decrease of 1.58.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 5.08 (Mar 23) to 3.50, marking a decrease of 1.58.
  • For Cash EPS (Rs.), as of Mar 24, the value is 4.41. This value is within the healthy range. It has decreased from 5.96 (Mar 23) to 4.41, marking a decrease of 1.55.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 30.83. It has increased from 28.26 (Mar 23) to 30.83, marking an increase of 2.57.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 30.83. It has increased from 28.26 (Mar 23) to 30.83, marking an increase of 2.57.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 33.97. It has decreased from 38.23 (Mar 23) to 33.97, marking a decrease of 4.26.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 6.04. This value is within the healthy range. It has decreased from 8.09 (Mar 23) to 6.04, marking a decrease of 2.05.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 5.12. This value is within the healthy range. It has decreased from 7.22 (Mar 23) to 5.12, marking a decrease of 2.10.
  • For PBT / Share (Rs.), as of Mar 24, the value is 4.67. This value is within the healthy range. It has decreased from 6.86 (Mar 23) to 4.67, marking a decrease of 2.19.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 3.50. This value is within the healthy range. It has decreased from 5.08 (Mar 23) to 3.50, marking a decrease of 1.58.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.50. This value is within the healthy range. It has decreased from 5.08 (Mar 23) to 3.50, marking a decrease of 1.58.
  • For PBDIT Margin (%), as of Mar 24, the value is 17.76. This value is within the healthy range. It has decreased from 21.17 (Mar 23) to 17.76, marking a decrease of 3.41.
  • For PBIT Margin (%), as of Mar 24, the value is 15.08. This value is within the healthy range. It has decreased from 18.87 (Mar 23) to 15.08, marking a decrease of 3.79.
  • For PBT Margin (%), as of Mar 24, the value is 13.73. This value is within the healthy range. It has decreased from 17.95 (Mar 23) to 13.73, marking a decrease of 4.22.
  • For Net Profit Margin (%), as of Mar 24, the value is 10.30. This value exceeds the healthy maximum of 10. It has decreased from 13.29 (Mar 23) to 10.30, marking a decrease of 2.99.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.30. This value is within the healthy range. It has decreased from 13.29 (Mar 23) to 10.30, marking a decrease of 2.99.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 11.34. This value is below the healthy minimum of 15. It has decreased from 17.98 (Mar 23) to 11.34, marking a decrease of 6.64.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 16.08. This value is within the healthy range. It has decreased from 24.68 (Mar 23) to 16.08, marking a decrease of 8.60.
  • For Return On Assets (%), as of Mar 24, the value is 8.90. This value is within the healthy range. It has decreased from 14.83 (Mar 23) to 8.90, marking a decrease of 5.93.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.07. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 0.07.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.92. It has decreased from 1.21 (Mar 23) to 0.92, marking a decrease of 0.29.
  • For Current Ratio (X), as of Mar 24, the value is 4.53. This value exceeds the healthy maximum of 3. It has decreased from 5.75 (Mar 23) to 4.53, marking a decrease of 1.22.
  • For Quick Ratio (X), as of Mar 24, the value is 2.57. This value exceeds the healthy maximum of 2. It has decreased from 2.98 (Mar 23) to 2.57, marking a decrease of 0.41.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.94. This value is below the healthy minimum of 4. It has decreased from 1.45 (Mar 23) to 0.94, marking a decrease of 0.51.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 25.71. This value is within the healthy range. It has increased from 19.67 (Mar 23) to 25.71, marking an increase of 6.04.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 20.40. This value is within the healthy range. It has increased from 16.77 (Mar 23) to 20.40, marking an increase of 3.63.
  • For Earning Retention Ratio (%), as of Mar 24, the value is 74.29. This value exceeds the healthy maximum of 70. It has decreased from 80.33 (Mar 23) to 74.29, marking a decrease of 6.04.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 79.60. This value exceeds the healthy maximum of 70. It has decreased from 83.23 (Mar 23) to 79.60, marking a decrease of 3.63.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 13.20. This value is within the healthy range. It has decreased from 23.02 (Mar 23) to 13.20, marking a decrease of 9.82.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 8.65. This value is within the healthy range. It has decreased from 15.46 (Mar 23) to 8.65, marking a decrease of 6.81.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 1,285.96. It has increased from 1,216.71 (Mar 23) to 1,285.96, marking an increase of 69.25.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.49. This value is within the healthy range. It has increased from 2.09 (Mar 23) to 2.49, marking an increase of 0.40.
  • For EV / EBITDA (X), as of Mar 24, the value is 13.99. This value is within the healthy range. It has increased from 9.87 (Mar 23) to 13.99, marking an increase of 4.12.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.47. This value is within the healthy range. It has increased from 2.07 (Mar 23) to 2.47, marking an increase of 0.40.
  • For Retention Ratios (%), as of Mar 24, the value is 74.28. This value exceeds the healthy maximum of 70. It has decreased from 80.32 (Mar 23) to 74.28, marking a decrease of 6.04.
  • For Price / BV (X), as of Mar 24, the value is 2.72. This value is within the healthy range. It has decreased from 2.80 (Mar 23) to 2.72, marking a decrease of 0.08.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.47. This value is within the healthy range. It has increased from 2.07 (Mar 23) to 2.47, marking an increase of 0.40.
  • For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 23) to 0.04, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of AVT Natural Products Ltd as of April 25, 2025 is: 62.95

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 25, 2025, AVT Natural Products Ltd is Undervalued by 1.53% compared to the current share price 62.00

Intrinsic Value of AVT Natural Products Ltd as of April 25, 2025 is: 62.82

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 25, 2025, AVT Natural Products Ltd is Undervalued by 1.32% compared to the current share price 62.00

Last 5 Year EPS CAGR: -0.20%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 23.17%, which is a positive sign.
  2. The company has higher reserves (272.69 cr) compared to borrowings (37.69 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (394.85 cr) and profit (58.08 cr) over the years.
  1. The stock has a high average Working Capital Days of 171.83, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 281.58, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AVT Natural Products Ltd:
    1. Net Profit Margin: 10.3%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 16.08% (Industry Average ROCE: 13.13%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 11.34% (Industry Average ROE: 16.33%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 8.65
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.57
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 21.1 (Industry average Stock P/E: 40.38)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.07
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

AVT Natural Products Ltd. is a Public Limited Listed company incorporated on 12/03/1986 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L15142TN1986PLC012780 and registration number is 012780. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 503.31 Cr. and Equity Capital is Rs. 15.23 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Agricultural Products60, Rukmani Lakshmipathy Salai, Egmore, Chennai (Madras) Tamil Nadu 600008avtnpl@avtnatural.com
http://www.avtnatural.com
Management
NamePosition Held
Mr. Ajit ThomasChairman
Mr. A D BopanaDirector
Mrs. Shanthi ThomasDirector
Mr. Habib HussainDirector
Mrs. Kavitha VijayDirector

FAQ

What is the intrinsic value of AVT Natural Products Ltd?

AVT Natural Products Ltd's intrinsic value (as of 25 April 2025) is ₹62.95 — 1.53% higher the current market price of 62.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 947 Cr. market cap, FY2025-2026 high/low of ₹103/51.0, reserves of 460 Cr, and liabilities of 719 Cr.

What is the Market Cap of AVT Natural Products Ltd?

The Market Cap of AVT Natural Products Ltd is 947 Cr..

What is the current Stock Price of AVT Natural Products Ltd as on 25 April 2025?

The current stock price of AVT Natural Products Ltd as on 25 April 2025 is 62.0.

What is the High / Low of AVT Natural Products Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of AVT Natural Products Ltd stocks is ₹103/51.0.

What is the Stock P/E of AVT Natural Products Ltd?

The Stock P/E of AVT Natural Products Ltd is 21.1.

What is the Book Value of AVT Natural Products Ltd?

The Book Value of AVT Natural Products Ltd is 31.2.

What is the Dividend Yield of AVT Natural Products Ltd?

The Dividend Yield of AVT Natural Products Ltd is 1.29 %.

What is the ROCE of AVT Natural Products Ltd?

The ROCE of AVT Natural Products Ltd is 15.9 %.

What is the ROE of AVT Natural Products Ltd?

The ROE of AVT Natural Products Ltd is 11.8 %.

What is the Face Value of AVT Natural Products Ltd?

The Face Value of AVT Natural Products Ltd is 1.00.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in AVT Natural Products Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE